Featured
Witnesses to a Revolution: Senior Retina Specialists Reflect on Practice in the Anti-VEGF Era
Part 1 of a 3-part series on medical and surgical retina.
By Susan L. Worley, contributing writer
Aqueous Humor Biopsy for Retinoblastoma
New methods could facilitate diagnosis for children with retinoblastoma.
Eylea/Ang2 Combo Disappoints in Phase 2
Results do not warrant phase 3 development, according to the company.
FDA Approves Spark Gene Therapy for IRD
First to target a specific gene mutation.
Phase 3 Brolucizumab Data Impress at AAO
Drug scores high on key metrics in wet AMD study.
Retinal Breaks: Clinical Course and Outcomes After Retinopexy
Patients are at risk for new retinal breaks or even retinal detachment in spite of retinopexy.
How Has Retinoblastoma Changed Since My Residency?
Stay up to date on rapidly changing therapies.
MACRA’s Evolving Impact on Retina
Despite significant regulatory rollback this year, retinal physicians remain vulnerable to penalties.
Pars Plana Vitrectomy in Uveitis Management
Data are scant on this important tool for diagnosis and treatment of uveitis.
Causes and Treatment Options for Postsurgical Cystoid Macular Edema
Part 3 of a 3-part series on cystoid macular edema.
The Importance of Assessing Low Vision in Retina Practice
Retina specialists can help improve quality of life in patients with residual low vision.
Logistics of Genetic Testing: An Overview for Retina Specialists
What you need to know about genetic testing laboratories to help your patients.
SUBSPECIALTY NEWS
By PAUL A. YATES, MD, PHD
UVEITIS CORNER: How to Approach Surgery for Uveitis Patients
Tailor your treatment plan to the patient.
CODING Q&A: Designated Health Services: What You Need to Know
The Stark Law prohibits physician self-referrals. Here’s what that means for you in daily practice.
NEW PRODUCT APPLICATIONS: Widening the Imaging Field
The Zeiss CLARUS 500 ultrawidefield system provides true color and clarity.
LONG-TERM MANAGEMENT OF ADVANCED AMD
TAKING RESEARCH TO THE CLINIC